3D printed hydroxyurea for pediatric use: toward personalized formulations and reduced exposure risk.
Saved in:
| Title: | 3D printed hydroxyurea for pediatric use: toward personalized formulations and reduced exposure risk. |
|---|---|
| Authors: | Laverdière J; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: jean.laverdiere@umontreal.ca., Bendicho-Lavilla C; FABRX Artificial Intelligence, Calle Enrique Vidal Abascal 7, 15702 Santiago de Compostela, Spain; FABRX Ltd., Henwood House, Henwood, Ashford, Kent TN24 8DH, UK. Electronic address: carlos.bendicho@fabrx.co.uk., Mahrouche L; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: louiza.mahrouche@umontreal.ca., Friciu M; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: mihaela.friciu@umontreal.ca., Pastore Y; Pediatric Department, Hematology Section, CHU Sainte-Justine, 3175 Chem. de la Côte-Sainte-Catherine, Montréal H3T 1C5, Canada. Electronic address: yves.pastore.med@ssss.gouv.qc.ca., Leclair G; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: gregoire.leclair@umontreal.ca., Basit AW; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK. Electronic address: a.basit@ucl.ac.uk., Goyanes A; FABRX Artificial Intelligence, Calle Enrique Vidal Abascal 7, 15702 Santiago de Compostela, Spain; FABRX Ltd., Henwood House, Henwood, Ashford, Kent TN24 8DH, UK; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela 15782 Santiago de Compostela, Spain. Electronic address: a.goyanes@fabrx.co.uk., Roullin VG; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: vg.roullin@umontreal.ca. |
| Source: | International journal of pharmaceutics [Int J Pharm] 2025 Dec 25; Vol. 686, pp. 126326. Date of Electronic Publication: 2025 Oct 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41167453 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 3D printed hydroxyurea for pediatric use: toward personalized formulations and reduced exposure risk. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Laverdière+J%22">Laverdière J</searchLink>; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: jean.laverdiere@umontreal.ca.<br /><searchLink fieldCode="AU" term="%22Bendicho-Lavilla+C%22">Bendicho-Lavilla C</searchLink>; FABRX Artificial Intelligence, Calle Enrique Vidal Abascal 7, 15702 Santiago de Compostela, Spain; FABRX Ltd., Henwood House, Henwood, Ashford, Kent TN24 8DH, UK. Electronic address: carlos.bendicho@fabrx.co.uk.<br /><searchLink fieldCode="AU" term="%22Mahrouche+L%22">Mahrouche L</searchLink>; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: louiza.mahrouche@umontreal.ca.<br /><searchLink fieldCode="AU" term="%22Friciu+M%22">Friciu M</searchLink>; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: mihaela.friciu@umontreal.ca.<br /><searchLink fieldCode="AU" term="%22Pastore+Y%22">Pastore Y</searchLink>; Pediatric Department, Hematology Section, CHU Sainte-Justine, 3175 Chem. de la Côte-Sainte-Catherine, Montréal H3T 1C5, Canada. Electronic address: yves.pastore.med@ssss.gouv.qc.ca.<br /><searchLink fieldCode="AU" term="%22Leclair+G%22">Leclair G</searchLink>; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: gregoire.leclair@umontreal.ca.<br /><searchLink fieldCode="AU" term="%22Basit+AW%22">Basit AW</searchLink>; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK. Electronic address: a.basit@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Goyanes+A%22">Goyanes A</searchLink>; FABRX Artificial Intelligence, Calle Enrique Vidal Abascal 7, 15702 Santiago de Compostela, Spain; FABRX Ltd., Henwood House, Henwood, Ashford, Kent TN24 8DH, UK; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela 15782 Santiago de Compostela, Spain. Electronic address: a.goyanes@fabrx.co.uk.<br /><searchLink fieldCode="AU" term="%22Roullin+VG%22">Roullin VG</searchLink>; Platform of Biopharmacy, Université de Montréal, 2940 Chem. de Polytechnique, Montréal H3T 1J4, Canada. Electronic address: vg.roullin@umontreal.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227804127%22">International journal of pharmaceutics</searchLink> [Int J Pharm] 2025 Dec 25; Vol. 686, pp. 126326. <i>Date of Electronic Publication: </i>2025 Oct 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2FNorth-Holland+Biomedical+Press%22">Elsevier/North-Holland Biomedical Press </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>7804127 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-3476 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203785173%22">03785173 </searchLink><i>NLM ISO Abbreviation: </i>Int J Pharm <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41167453 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ijpharm.2025.126326 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 126326 Titles: – TitleFull: 3D printed hydroxyurea for pediatric use: toward personalized formulations and reduced exposure risk. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Laverdière J – PersonEntity: Name: NameFull: Bendicho-Lavilla C – PersonEntity: Name: NameFull: Mahrouche L – PersonEntity: Name: NameFull: Friciu M – PersonEntity: Name: NameFull: Pastore Y – PersonEntity: Name: NameFull: Leclair G – PersonEntity: Name: NameFull: Basit AW – PersonEntity: Name: NameFull: Goyanes A – PersonEntity: Name: NameFull: Roullin VG IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 12 Text: 2025 Dec 25 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1873-3476 Numbering: – Type: volume Value: 686 Titles: – TitleFull: International journal of pharmaceutics Type: main |
| ResultId | 1 |